Cheng Luo
Impact in
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Sphingolipid Metabolism and Signaling
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 64
- Cancer-related gene regulation 52
- Protein Degradation and Inhibitors 50
- Ubiquitin and proteasome pathways 36
- RNA modifications and cancer 25
- Histone Deacetylase Inhibitors Research 24
- Oncology 56
- Co-authors
- Hualiang Jiang (138 shared papers)Kaixian Chen (74 shared papers)Nitai C. Hait (5 shared papers)Zhongjie Liang (39 shared papers)Sarah Spiegel (5 shared papers)Jeremy C. Allegood (4 shared papers)Sheldon Milstien (4 shared papers)Junyan Lu (29 shared papers)
- Journals
- Journal of Medicinal Chemistry (37 papers)European Journal of Medicinal Chemistry (21 papers)Bioorganic & Medicinal Chemistry Letters (20 papers)PLoS ONE (14 papers)Bioorganic & Medicinal Chemistry (13 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Cheng Luo
451 papers receiving 13.4k citations
Cheng Luo's Hit Papers
Peers
Comparison fields: 5 of 186
- Molecular Biology 8.6k
- Cancer Research 1.3k
- Computational Theory and Mathematics 962
- Oncology 1.2k
- Organic Chemistry 1.4k
Countries citing papers authored by Cheng Luo
This map shows the geographic impact of Cheng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Luo more than expected).
Fields of papers citing papers by Cheng Luo
This network shows the impact of papers produced by Cheng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Luo. The network helps show where Cheng Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 465 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate Hit paper breakdown → | 2009 | 813 |
| 2 | Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2 Hit paper breakdown → | 2010 | 620 |
| 3 | Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5 Hit paper breakdown → | 2014 | 567 |
| 4 | 2012 | 392 | |
| 5 | 2015 | 275 | |
| 6 | 2012 | 252 | |
| 7 | 2012 | 238 | |
| 8 | 2006 | 222 | |
| 9 | 2015 | 179 | |
| 10 | 2014 | 168 | |
| 11 | 2017 | 166 | |
| 12 | 2014 | 162 | |
| 13 | 2021 | 143 | |
| 14 | 2012 | 142 | |
| 15 | 2014 | 137 | |
| 16 | Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1 Hit paper breakdown → | 2023 | 124 |
| 17 | 2017 | 124 | |
| 18 | 2017 | 115 | |
| 19 | 2020 | 112 | |
| 20 | 2012 | 110 |
About Cheng Luo
Cheng Luo is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Cancer Research and Immunology, having authored 465 papers that have together received 13.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (64 papers), Cancer-related gene regulation (52 papers), Protein Degradation and Inhibitors (50 papers), Ubiquitin and proteasome pathways (36 papers), Computational Drug Discovery Methods (25 papers), RNA modifications and cancer (25 papers), Histone Deacetylase Inhibitors Research (24 papers) and Multiple Myeloma Research and Treatments (20 papers). The work is most often cited by research in Molecular Biology (8.6k citations), Cancer Research (1.3k citations), Computational Theory and Mathematics (962 citations), Oncology (1.2k citations) and Organic Chemistry (1.4k citations). Cheng Luo has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Hualiang Jiang, Kaixian Chen, Nitai C. Hait, Zhongjie Liang, Sarah Spiegel, Jeremy C. Allegood, Sheldon Milstien, Junyan Lu, Kuzhuvelil B. Harikumar and Tomasz Kordula. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, PLoS ONE and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.